Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18922107

Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Expert Opin Investig Drugs
Publication date
2008 Nov
First author
Anderson P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Anderson P
      type
      Author
    2. name
      Kopp L
      type
      Author
    3. name
      Anderson N
      type
      Author
    4. name
      Cornelius K
      type
      Author
    5. name
      Herzog C
      type
      Author
    6. name
      Hughes D
      type
      Author
    7. name
      Huh W
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Anderson P
      type
      Author
    2. name
      Kopp L
      type
      Author
    3. name
      Anderson N
      type
      Author
    4. name
      Cornelius K
      type
      Author
    5. name
      Herzog C
      type
      Author
    6. name
      Hughes D
      type
      Author
    7. name
      Huh W
      type
      Author
    bibliography ids
    1. nci-bib-fefab38bb56192183e8f48ae
    book metadata
    content sha256
    5c389bfe5b603b04b895654f0c14e696c804ff704baa055ef576ee7c4e5d0151
    document type
    citation
    dois
    1. 10.1517/13543784.17.11.1703
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18922107
    immutable id
    pubmed:18922107@5c389bfe5b603b04b895654f0c14e696c804ff704baa055ef576ee7c4e5d0151
    journal
    abbreviation
    Expert Opin Investig Drugs
    issn electronic
    1744-7658
    issn print
    1354-3784
    issue
    11
    name
    Expert opinion on investigational drugs
    nlm unique id
    9434197
    pages
    1703-15
    volume
    17
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18922107
      provenance
      batch id
      6281e3e555c9a831cffc
      provider
      NCBI PubMed ESummary
      record sha256
      6d38c3122c4d00ce9a16f1639c582585b5008a638f5b8c64ccf1c21996296dd3
      response sha256
      0bb4ba3914464c472d4206a84abe8224c9e76dc003114204593648964c5bf66c
      retrieved at
      2026-09-09T23:46:21.772457+00:00
      publication date
      display
      2008 Nov
      precision
      month
      year
      2008
      publication types
      1. Journal Article
      2. Review
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18922107/
      title
      Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma).

      Preserved source evidence · Not medical advice